Drug profile · INN
insulin human
COMBIMARV
insulin human (COMBIMARV) is a insulin receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — insulin human
- US status
- approved
- Class
- Alimentary tract and metabolism (A10)
- Route
- SUBCUTANEOUS
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
insulin human (COMBIMARV) is a insulin receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Mechanism of action
Insulin receptor agonist
Primary target: Insulin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is insulin human?
insulin human (COMBIMARV) is a insulin receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for insulin human?
COMBIMARV is a marketed brand name for insulin human. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin human?
insulin human has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.